Sohrab Arora
Overview
Explore the profile of Sohrab Arora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cirulli G, Stephens A, Chiarelli G, Finati M, Bertini A, Chase M, et al.
Prostate
. 2025 Jan;
e24856.
PMID: 39869547
Introduction: PSA screening remains a pivotal tool for early prostate cancer (PCa) detection. International guidelines rely on evidence from three major randomized clinical trials: ERSPC, PLCO, and CAP. We aim...
2.
Cirulli G, Davis M, Stephens A, Chiarelli G, Finati M, Chase M, et al.
Cancer
. 2024 Oct;
131(1):e35563.
PMID: 39377255
Background: Midlife baseline prostate-specific antigen (MB PSA), defined as a single PSA value measured between 40-59 years of age, has been proposed as a tool that can limit potential harms...
3.
Tinsley S, Arora S, Stephens A, Finati M, Chiarelli G, Cirulli G, et al.
World J Urol
. 2024 Aug;
42(1):465.
PMID: 39090376
Purpose: This study examined the impact of cannabis use disorder (CUD) on inpatient morbidity, length of stay (LOS), and inpatient cost (IC) of patients undergoing urologic oncologic surgery. Methods: The...
4.
Chiarelli G, Stephens A, Finati M, Cirulli G, Beatrici E, Filipas D, et al.
Int Urol Nephrol
. 2024 Apr;
56(8):2589-2595.
PMID: 38564079
Purpose: We aimed to assess the appropriateness of ChatGPT in providing answers related to prostate cancer (PCa) screening, comparing GPT-3.5 and GPT-4. Methods: A committee of five reviewers designed 30...
5.
Corsi N, Stephens A, Finati M, Malchow T, Morrison C, Davis M, et al.
Urol Oncol
. 2024 Mar;
42(6):175.e19-175.e25.
PMID: 38522975
Objective: The European POUT III randomized controlled trial provided level-one evidence that adjuvant platinum-based chemotherapy is the standard of care following nephroureterectomy (RNU) for locally invasive or node-positive upper tract...
6.
Dalela D, Corsi N, Bronkema C, Sood A, Arora S, Majdalany S, et al.
Clin Genitourin Cancer
. 2024 Jan;
22(2):269-280.e2.
PMID: 38233279
Background: Estimation of life expectancy (LE) is important for the relative benefit of prostate specific antigen (PSA) screening. Limited data exists regarding screening for Black men with extended LE. The...
7.
Arora S, Chen I, Bronkema C, Chiarelli G, Finati M, Cirulli G, et al.
Urology
. 2023 Dec;
184:94-100.
PMID: 38160761
Objective: To assess the incidence, cumulative healthcare burden, and financial impact of inpatient admissions for radiation cystitis (RC), while exploring practice differences in RC management between teaching and nonteaching hospitals....
8.
Dielubanza E, Arora S, Atiemo H
Urol Clin North Am
. 2023 Sep;
50(4):495-500.
PMID: 37775208
Analysis of the urology match statistics provides a window into the future of the urology workforce. Match statistics from 2019 to 2023 were analyzed to determine whether the efforts to...
9.
Rakic I, Rakic N, Stephens A, Corsi N, Davis M, Tinsley S, et al.
Urol Oncol
. 2023 Aug;
41(10):435.e1-435.e9.
PMID: 37625905
Introduction: Lymph-vascular invasion (LVI) is recognized as an adverse pathological feature in patients with renal cell carcinoma (RCC). However, its impact on overall survival (OS) is not clear and scarcely...
10.
Majdalany S, Yaguchi G, Arora S, Ray C, Atiemo H, Raza J
Urology
. 2023 Jun;
179:202-203.
PMID: 37321278
Objective: Vaginal prolapse is a known complication after radical cystectomy, requiring additional procedures in 10% of the patients. This results from loss of level I and II vaginal support due...